...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: 10 Year Anniversary for Resverlogix's Newco !!

,,NBB,,,,I get the time lag,,,,and the incredible risk,,,,we bought that way back!,,,,we also bought into the nursey concept which was their business model,,,,,hummmm,,,,never happened!!,,,,cant drum up research interest in epigenetics on other molecules??,,,,cant evolve the model?,,,,,cant license other molecules to prospective Pharmas,,,,cant,,,,wont,,,couldnt,,shouldnt ,,,,Zzzzzzzz,,, Zzzzzzz,,, Zzzzzzzzz,,,,,we need to wear a CPAP while in wait for advancement,,,,,,,,and still our shares are at arms length,,,,,ugghhhhhhhhhh!!!

Share
New Message
Please login to post a reply